Silexion Therapeutics Announces Preclinical Data Showing SIL204 Upregulated FAS And Downregulated HLA-G Across Three KRAS-Mutant Pancreatic And NSCLC Cell Lines

뉴스 본문을 불러오고 있어요.

Silexion Therapeutics Announces Preclinical Data Showing SIL204 Upregulated FAS And Downregulated HLA-G Across Three KRAS-Mutant Pancreatic And NSCLC Cell Lines | 웨이프 WAPE

Silexion Therapeutics Announces Preclinical Data Showing SIL204 Upregulated FAS And Downregulated HLA-G Across Three KRAS-Mutant Pancreatic And NSCLC Cell Lines

기사 요약

관련 종목

댓글 —